From May 28th to May 29th, GUT2022×The 4th China Gut Industry Conference, a large-scale academic event on the intestinal theme hosted by the Rexinchang Biotechnology Research Institute, was grandly held. At this conference, Yili BL-99 won the “Intestinal Industry” annual domestic strain application breakthrough award.
May 29th is World Intestinal Health Day, and Yili co-hosted a forum on “China’s Patented Strain Innovation Trend and Chinese People’s Health”. Qin Huanlong, Dean of Shanghai Tenth People’s Hospital, Lan Canhui, Dean of Enthusiasm Research Institute, Professor Wang Xin, Vice Chairman of Probiotics, Prebiotics and Health Branch of Chinese Nutrition Society, Professor Li Hongwei of Xiamen University, Chairman of Pennant Biosciences Liu Xuecong, etc. Experts and industry representatives attended the conference to discuss topics such as the research and development of Chinese patented strains and the health of Chinese people.
my country has the largest elderly population in the world and one of the fastest aging countries in the world. During the “14th Five-Year Plan” period, my country’s population aging will further deepen, and the proportion of the population aged 60 and above will exceed 20% of the total population, entering a moderately aging society. The health status of the elderly is not optimistic. As the age continues to increase, the cognitive, motor and sensory functions of the elderly decline, as well as nutrition, psychological and other health problems. More than 78% of the elderly suffer from at least one chronic disease.
At the intestinal conference, Professor Wang Xin said that the intestinal flora is closely related to aging, and the flora of the elderly is affected by physiological age, environment and diseases. Decreased abundance of bifidobacteria in the gut. Probiotics can change the intestinal imbalance of the elderly. Probiotics, prebiotics, and a reasonable diet are one of the good solutions to improve the intestinal flora. Studies have shown that the combination of Bifidobacterium lactis BL-99 and the prebiotic fructooligosaccharide has a good effect on improving the structure of intestinal flora in constipated people and increasing the number of good intestinal bacteria such as Bifidobacterium.
Professor Li Hongwei of Xiamen University said that with the increase of age, the prevalence of osteoporosis increases, and bone problems are the key issues that need to be paid attention to in healthy aging . Specific probiotics, especially Erie’s Bifidobacterium lactis BL-99, can reduce bone loss through the “gut-bone” axis, while modulating the balance of gut flora. Daily intake of Bifidobacterium lactis BL-99 has a certain alleviation effect on bone loss caused by enteritis.
Liu Xuecong, Chairman of Penn Banner Biological Group, proposed that “one side of the water and soil raises one person”, due to differences in ethnicity, region, living habits, diet, etc., Chinese and Western people The structure of the intestinal flora is different, and the probiotics suitable for supplementation may also be different. Lactobacillus rhamnosus MP108, represented by Pennant Bio, is the first Chinese strain to obtain regulatory approval for strains available for infants and young children. Bifidobacterium iliis BL-99 has also formed a good case of industry-university-research transformation for China’s self-developed probiotics.
Yili Group’s R&D personnel said that relying on Yili’s leading global innovation network layout, Yili already has the construction of probiotic strain resource bank, probiotic function development and There are four research and development platforms: clinical evaluation, strain application and fermentation technology, strain technology and quality system. Among them, Bifidobacterium lactis BL-99 is the first strain independently developed by Yili after 10 years of scientific research and isolated from the intestinal tract of healthy Chinese infants. It has obtained 5 Chinese patent certifications and 1 international patent authorization. Studies have shown that BL-99 has the effects of promoting digestive health, improving immunity, promoting bone health, and regulating intestinal flora. Thick-cut cheese slices, cheese sticks, Yixiaosheng freeze-dried yogurt cubes and Yixiao freeze-dried yogurt beans are among the series of products. Yili Health Science BL-99 probiotic innovative product adopts Chinese patented strain BL-99, with dietary fiber and γ-aminobutyric acid, to meet the market demand of healthy aging.
At the meeting, President Qin Huanlong of Shanghai Tenth People’s Hospital emphasized: “After nearly ten years of hard work, the intestinal microecology and individual The research on chemical probiotics is booming, and basic research, clinical research and application transformation are becoming more and more close. The development of a new probiotic must pay attention to the inclusiveness, competitiveness and bioavailability of intestinal flora. Today, we see in the enterprise Driven by the integration of experts, scientists, and industry-university-research, the research and development of probiotics has gradually moved towards the road of large-scale and rapid development, and the research and development and development of patented strains require the joint efforts of people from all walks of life.” Lan Canhui, Dean of the Enthusiasm Research Institute Said: “Yili has done a lot of work in the independent research and development of probiotics. Yili’s star strain represented by BL-99 has produced valuable scientific achievements and played a good role in the transformation of production, education and research in the field of probiotics.”
In the future, Yili will continue to strengthen the layout of probiotics categories, strengthen cooperation with upstream and downstream partners in the industry chain, actively innovate cooperation models and product transformation mechanisms, and jointly build a healthy probiotics ecosystem. Demand for the development and transformation of functional nutritional products to achieve consumer value leadership.